Recordati SpA (RCDTF)
58.00
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Recordati Shareholders Equity (Quarterly) : 2.436B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.436B |
| March 31, 2026 | 2.374B |
| December 31, 2025 | 2.236B |
| September 30, 2025 | 2.265B |
| June 30, 2025 | 2.196B |
| March 31, 2025 | 2.136B |
| December 31, 2024 | 1.927B |
| September 30, 2024 | 2.094B |
| June 30, 2024 | 1.934B |
| March 31, 2024 | 1.963B |
| December 31, 2023 | 1.863B |
| September 30, 2023 | 1.826B |
| June 30, 2023 | 1.756B |
| March 31, 2023 | 1.797B |
| December 31, 2022 | 1.650B |
| September 30, 2022 | 1.578B |
| June 30, 2022 | 1.562B |
| March 31, 2022 | 1.613B |
| December 31, 2021 | 1.571B |
| September 30, 2021 | 1.675B |
| June 30, 2021 | 1.575B |
| March 31, 2021 | 1.562B |
| December 31, 2020 | 1.561B |
| September 30, 2020 | 1.510B |
| June 30, 2020 | 1.395B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.364B |
| December 31, 2019 | 1.345B |
| September 30, 2019 | 1.286B |
| June 30, 2019 | 1.220B |
| March 31, 2019 | 1.198B |
| December 31, 2018 | 1.101B |
| September 30, 2018 | 1.147B |
| June 30, 2018 | 1.082B |
| March 31, 2018 | 1.147B |
| December 31, 2017 | 1.233B |
| September 30, 2017 | 1.247B |
| June 30, 2017 | 1.130B |
| March 31, 2017 | 1.066B |
| December 31, 2016 | 953.31M |
| September 30, 2016 | 1.111B |
| June 30, 2016 | 1.032B |
| March 31, 2016 | 1.044B |
| December 31, 2015 | 944.98M |
| September 30, 2015 | 1.004B |
| June 30, 2015 | 974.68M |
| March 31, 2015 | 928.89M |
| December 31, 2014 | 952.73M |
| September 30, 2014 | 1.035B |
| June 30, 2014 | 1.057B |
| March 31, 2014 | 1.023B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 47.33B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Avadel Pharmaceuticals Plc | 98.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.138B |
| Total Liabilities (Quarterly) | 3.702B |
| Debt to Equity Ratio | 1.084 |
| Current Ratio | 1.256 |
| Net Debt Paydown Yield | -0.16% |